133 related articles for article (PubMed ID: 10613320)
21. Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions.
Withers HR; Peters LJ; Taylor JM; Owen JB; Morrison WH; Schultheiss TE; Keane T; O'Sullivan B; van Dyk J; Gupta N
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):549-62. PubMed ID: 7558943
[TBL] [Abstract][Full Text] [Related]
22. Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data.
Semenenko VA; Li XA
Phys Med Biol; 2008 Feb; 53(3):737-55. PubMed ID: 18199912
[TBL] [Abstract][Full Text] [Related]
23. Fundamental form of a population TCP model in the limit of large heterogeneity.
Carlone MC; Warkentin B; Stavrev P; Fallone BG
Med Phys; 2006 Jun; 33(6):1634-42. PubMed ID: 16872071
[TBL] [Abstract][Full Text] [Related]
24. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.
Maciejewski B; Withers HR; Taylor JM; Hliniak A
Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):831-43. PubMed ID: 2921175
[TBL] [Abstract][Full Text] [Related]
25. Derivation of the optimum dose per fraction from the linear quadratic model.
Jones B; Tan LT; Dale RG
Br J Radiol; 1995 Aug; 68(812):894-902. PubMed ID: 7551788
[TBL] [Abstract][Full Text] [Related]
26. Substructure in the radiation survival response at low dose in cells of human tumor cell lines.
Skarsgard LD; Skwarchuk MW; Wouters BG; Durand RE
Radiat Res; 1996 Oct; 146(4):388-98. PubMed ID: 8927711
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity of human squamous cell carcinoma of the larynx to fractionated radiotherapy.
Rezvani M; Fowler JF; Hopewell JW; Alcock CJ
Br J Radiol; 1993 Mar; 66(783):245-55. PubMed ID: 8472118
[TBL] [Abstract][Full Text] [Related]
28. The effect of fractionated doses of radiation on mouse spinal cord.
Lo Y; Taylor JM; McBride WH; Withers HR
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):309-17. PubMed ID: 8407405
[TBL] [Abstract][Full Text] [Related]
29. How worthwhile are short schedules in radiotherapy? A series of exploratory calculations.
Fowler JF
Radiother Oncol; 1990 Jun; 18(2):165-81. PubMed ID: 2367691
[TBL] [Abstract][Full Text] [Related]
30. Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT).
Wang JZ; Li XA; D'Souza WD; Stewart RD
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):543-52. PubMed ID: 12957268
[TBL] [Abstract][Full Text] [Related]
31. Steepness of the clinical dose-control curve and variation in the in vitro radiosensitivity of head and neck squamous cell carcinoma.
Bentzen SM
Int J Radiat Biol; 1992 Mar; 61(3):417-23. PubMed ID: 1347075
[TBL] [Abstract][Full Text] [Related]
32. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
Pop LA; Millar WT; Visser AG; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
[TBL] [Abstract][Full Text] [Related]
33. Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx.
Clark CH; Bidmead AM; Mubata CD; Harrington KJ; Nutting CM
Radiother Oncol; 2004 Feb; 70(2):189-98. PubMed ID: 15028407
[TBL] [Abstract][Full Text] [Related]
34. Estimation of optimum dose per fraction for high LET radiations: implications for proton radiotherapy.
Jones B; Dale RG
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1549-57. PubMed ID: 11121661
[TBL] [Abstract][Full Text] [Related]
35. Intestinal crypt clonogens: a new interpretation of radiation survival curve shape and clonogenic cell number.
Roberts SA; Hendry JH; Potten CS
Cell Prolif; 2003 Aug; 36(4):215-31. PubMed ID: 12950390
[TBL] [Abstract][Full Text] [Related]
36. Clinical implications of heterogeneity of tumor response to radiation therapy.
Suit H; Skates S; Taghian A; Okunieff P; Efird JT
Radiother Oncol; 1992 Dec; 25(4):251-60. PubMed ID: 1480770
[TBL] [Abstract][Full Text] [Related]
37. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
King CR; DiPetrillo TA; Wazer DE
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):165-72. PubMed ID: 10656389
[TBL] [Abstract][Full Text] [Related]
38. Tumor radioresponsiveness versus fractionation sensitivity.
Thames HD; Suit HD
Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):687-91. PubMed ID: 3700173
[TBL] [Abstract][Full Text] [Related]
39. The reduction of tumour control with increasing overall time: mathematical considerations.
Jones B; Dale RG
Br J Radiol; 1996 Sep; 69(825):830-8. PubMed ID: 8983587
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system.
Stuschke M; Budach V; Stüben G; Streffer C; Sack H
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):395-408. PubMed ID: 7751182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
